Wasatch Global Investors released its Q4 2025 investor letter, showing a challenging quarter for the Small Cap Growth Strategy. While the Russell 2000 Growth Index gained 1.22%, the strategy finished in negative territory, impacted by stock-specific factors. Biotechnology emerged as a strong segment, with the biotech component of the index rising nearly 27%.

Fabrinet (NYSE:FN) was highlighted in the investor letter as a significant contributor to the portfolio. The company provides advanced optical and electronic manufacturing services, with increasing demand for its products in the telecommunications end markets. Fabrinet stock closed at approximately $462.05 per share on February 13, 2026, with a market capitalization of about $17.555 billion.

Fabrinet (NYSE:FN) is not among the 30 Most Popular Stocks Among Hedge Funds, with 44 hedge fund portfolios holding the stock at the end of the third quarter. While acknowledging the risk and potential of Fabrinet as an investment, some AI stocks are believed to hold greater promise for delivering higher returns. Investors looking for an undervalued AI stock with significant potential can access a free report on the best short-term AI stock.

Read more at Yahoo Finance: Fabrinet (FN) Advances as Optical Hardware Demand Strengthens